Gilead is going to start testing a drug it believes could prevent HIV infection with just a single shot every year.

Deaths from HIV/AIDS are ten times lower than at the peak of the epidemic, and new research could drive that down even more.

Smart syringes are medical devices engineered with safety mechanisms to prevent reuse of syringes and regulate unsafe injection practices. They are designed with features such as in-built inactivation ...

A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody ...

A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn’t respond to prior vaccination, ...

HIV Vaccine Trials Network external relations program manager Dr. Daniel Driffin spoke at the 2024 White House World AIDS Day ...

The Project Manager will have overall responsibility for ensuring implementation of Taskforce actions and overall coordination of their meetings and activities. Scope of work With support from ...

A drug used to treat HIV that has also shown promise in preventing infections is not a cure for those already infected, as ...

A new study has found that a twice-yearly injection of lenacapavir can reduce the risk of HIV by 96%.

A new injectable drug for HIV prevention, lenacapavir, is being hailed as a potential game-changer in the fight against the ...

While there's been a 35 per cent jump in human immunodeficiency virus (HIV) cases across Canada, the numbers have stabilized in northwestern Ontario — and health-care workers largely attribute it to ...

Rwanda is set to roll out the long-acting injectable PrEP known as cabotegravir (CAB-LA). PrEP refers to the use of ...